Skip to main content
. 2020 Oct 26;130(12):6325–6337. doi: 10.1172/JCI140378

Figure 5. A patient who demonstrated a continued expansion of H3.3K27M-reactive CD8+ T cells.

Figure 5

(A) MR images of a patient at baseline (left), week 12 (second from left), week 24 (second from right), and week 36 (far right). The patient (PNOC007-25) was found to have local progression in week 36. (B) Plot shows the longitudinal percentage of H3.3K27M-reactive CD8+ T cell subpopulations among live PBMCs. (C) Plot depicts the longitudinal percentage of circulatory MDSC subsets among live PBMCs.